Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Cancer Discov. 2012 Sep 5;2(10):922–933. doi: 10.1158/2159-8290.CD-12-0108

Table 1.

EGFR T790M and HER2 status in 26 EGFR-mutant tumors from patients with acquired resistance to erlotinib or gefitinib.

Gene status HER2 amp + HER2 amp −
EGFR T790M + 0 17
EGFR T790M − 3 6